In vitro, AD-like pathology can be induced in cultured cells or blood-brain organoids by exposing them to Aβ peptides, tau protein aggregates, or neuroinflammatory cytokines (Sharma et al., 2021; Schreiner et al., 2022). The gene discussed is MAPT; the disease is Alzheimer disease.